EOSINOPHILIC ESOPHAGITIS (EOE)
Clinical trials for EOSINOPHILIC ESOPHAGITIS (EOE) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ESOPHAGITIS (EOE) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ESOPHAGITIS (EOE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with swallowing trouble: drug targets esophagus inflammation
Disease control CompletedThis study tested a drug called dupilumab in 102 children with active eosinophilic esophagitis (EoE), a condition where the esophagus becomes inflamed, making swallowing painful. The goal was to see if dupilumab could reduce inflammation better than a placebo after 16 weeks. Rese…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Massive study probes cancer risk in EoE patients
Knowledge-focused CompletedThis study looked at health records of 100,000 people to find out if those with eosinophilic esophagitis (EoE) are more likely to develop esophageal cancer. Researchers wanted to see if any increased risk is due to EoE itself or other common conditions like GERD or Barrett's esop…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC